Sino Biopharmaceutical Limited (SBHMY) has a market capitalization of $14.2B and trades at $15.89. The 52-week range is 8.755-20.16.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 6.1, Earnings Per Share (EPS) of $2.60, annual revenue of $30.97B.
The stock has a beta of 0.72, a last dividend of $0.2305, operates in the Healthcare sector.
